Rankings
▼
Calendar
TKNO Q3 2023 Earnings — Alpha Teknova, Inc. Revenue & Financial Results | Market Cap Arena
TKNO
Alpha Teknova, Inc.
$133M
Q3 2023 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$8M
-23.6% YoY
Gross Profit
$1M
18.0% margin
Operating Income
-$9M
-107.3% margin
Net Income
-$10M
-124.3% margin
EPS (Diluted)
$-0.34
QoQ Revenue Growth
-29.1%
Cash Flow
Operating Cash Flow
-$4M
Free Cash Flow
-$5M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$138M
Total Liabilities
$39M
Stockholders' Equity
$100M
Cash & Equivalents
$32M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$8M
$11M
-23.6%
Gross Profit
$1M
$5M
-69.1%
Operating Income
-$9M
-$23M
+61.8%
Net Income
-$10M
-$22M
+54.8%
Revenue Segments
Lab Essentials
$7M
89%
Clinical Solutions
$597,000
7%
Other Product
$298,000
4%
Geographic Segments
UNITED STATES
$8M
96%
Non-US
$342,000
4%
← FY 2023
All Quarters
Q4 2023 →